Today, Biolink is pleased to announce the successful completion of a new multi-hundred million RMB strategic financing round. This round was led by Cathay Capital and included participation from disti...
Shanghai, China, April 15, 2024 - BioLink, a high-tech group enterprise equipped with state-of-the-art technology, specializing in the development and production of innovative bioprocessing products, ...
Recently, the 'iF Design Award', one of the world's three major design awards, officially announced its list of winners for the year 2024. In the list of awards, the BioHub® DS Single-U...
Today, BioLink proudly announced its successful completion of Series A+ strategic financing at the beginning of the Chinese Loong Year. This round of funding, led by Asymchem, Bridge Hill Capital, One...
BioLink, a prominent Chinese bioprocessing company, and the French downstream bioprocessing company Verdot signed a strategic partnership agreement that marks a significant step forward in the field o...
On November 3, 2023, the renowned media E Pharmaceutical Manager of China's medical and health industry officially released the list of 'Top 100 Chinese Life Science Service Enterprise Brands...
Upgrade of Chromatography Resin Manufacturing Site in Lanzhou, Empowering Safe, Efficient, and Sustainable Biopharmaceutical Separation and Purification Technology On June 30, 2023, the commissioning ...
CAR-T cell therapy has now become a new choice for tumor patients. Based on the high efficacy of CAR-T cell therapy shown in clinical studies, many front-line medical workers, patients and their families, and investigators in this field are very optimistic about it.
From June 21 to 24, BioLink made a stunning appearance with a series of new products at Analytica 2022 (Analytic & Laboratory Equipment Expo) held in Munich Exhibition Center , Germany after continuous R&D and innovation.
After being certified with "ISO 9001:2015", recently, BioLink Phas have been certified with "ISO 13485:2016" successfully after a strict and detailed review by the third-party testing and certification body.
This is the second time that Secretary Ding visited the company after one month, which fully shows the high concern and expectation that the Rugao Municipal Committee holds for the development of BioLink.
On the afternoon of Aug. 25, Ding Xinghua, Deputy Secretary of Rugao Municipal Committee and Deputy Secretary of the Party Working Committee of Rugao Economic and Technological Development Zone, and his party visited BioLink to inspect the construction of the biopharmaceutical single-use consumables manufacturing site.
On Oct. 18, 2021 Suzhou Wuzhong Taihu Lake Economic and Trade Cooperation Fair (hereinafter referred to as 'economic and trade fair') was grandly held on the shore of the beautiful Taihu Lake.
The 2021 5th China Bio-Pharm Innovation Cooperation Conference was held in Guangzhou during Nov. 4 to 5, 2021, attracting more than 900 industry representatives on the first day.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Visit our cookie policy to learn more.